Featured/ AKBA/ 10/28/2025 · 6:05 PM Akebia Therapeutics Halts Proposed Anemia Trial After FDA Feedback Akebia Therapeutics will not start its planned trial for Vafseo anemia treatment in non-dialysis kidney disease patients after the FDA requested a larger, costlier study.